2025-03-11 03:31:34
Latest Post
NTPC Group to Invest Rs 96,000 Crore in Chhattisgarh
Arvind Fashions aims to expand its CLUB A stores across India
Somany Ceramics Elevates Luxury with the launch of Duragres 2025 Collection
Cosmo Films Bags SIES SOP Star Awards 2025 for Innovative Packaging Materials
Zaggle Prepaid Ocean Services Ltd receives 'Financial Institution of the Year' Award
Stock Report
Solara Active Pharma Sciences Q3FY22 consolidated loss at Rs. 139.87 crores
Posted On : 2022-02-09 18:10:07( TIMEZONE : IST )
Solara Active Pharma Sciences Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 105.07 crores during the period ended December 31, 2021 as compared to Rs. 404.92 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. -139.87 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 29.71 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. -38.93 for the period ended December 31, 2021 as compared to Rs. 8.22 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 105.07 crs | ₹404.92 crs |  -74.05% |
| Net Profit | ₹-139.87 crs | ₹29.71 crs | -570.78% |
| EPS | ₹-38.93 | ₹8.22 | -573.60% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 105.07 crores during the period ended December 31, 2021 as compared to Rs.434.98 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-139.87 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.65.80 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.-38.93 for the period ended December 31, 2021 as compared to Rs.17.29 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 105.07 crs | ₹434.98 crs | -75.84% |
| Net Profit | ₹-139.87 crs | ₹65.80 crs | -312.57% |
| EPS | ₹-38.93 | ₹17.29 | -325.16% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.921.47 crores during the 9 Months period ended December 31, 2021 as compared to Rs.1191.66 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-60.03 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.164.75 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.-16.71 for the 9 Months period ended December 31, 2021 as compared to Rs.49.28 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹921.47 crs | ₹1191.66 crs | -22.67% |
| Net Profit | ₹-60.03 crs | ₹164.75 crs | -136.44% |
| EPS | ₹-16.71 | ₹49.28 | -133.91% |
Shares of Solara Active Pharma Sciences Limited was last trading in BSE at Rs. 968.80 as compared to the previous close of Rs. 957.95. The total number of shares traded during the day was 11890 in over 1385 trades.
The stock hit an intraday high of Rs. 976.00 and intraday low of 952.85. The net turnover during the day was Rs. 11464941.00.
